Banner

Ophthalmic solution reformulated as nasal spray for allergies

Article

Fort Worth, TX-A nasal formulation of olopatadine HCl ophthalmic solution 0.1% (Patanol, Alcon) reduced seasonal allergic rhinitis symptoms compared with placebo, according to phase III study results.

Related Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
Edward Manche, MD
Related Content

Study: Children with vision impairment have reduced quality of life

September 17th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

VUMC participates in national study to test eye drops for myopia

August 2nd 2023

Prevent Blindness declares August as children’s eye health and safety month

July 31st 2023

Study: Children with vision impairment have reduced quality of life

September 17th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

VUMC participates in national study to test eye drops for myopia

August 2nd 2023

Prevent Blindness declares August as children’s eye health and safety month

July 31st 2023

Study: Children with vision impairment have reduced quality of life

September 17th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

VUMC participates in national study to test eye drops for myopia

August 2nd 2023

Prevent Blindness declares August as children’s eye health and safety month

July 31st 2023
© 2023 MJH Life Sciences

All rights reserved.